Table 1 Prevalence of the antibody response in 200 individuals with patent Plasmodium vivax malaria
| Â | Number of positive sera (%) | |
|---|---|---|
Recombinant protein | IgG | IgM |
VIR-A4 | 22 (11.0) | 36 (18.1) |
VIR-B10 | 22 (11.0) | 18 (9.0) |
VIR-C1 | 23 (11.5) | 12 (6.0) |
VIR-C2 | 35 (17.5) | 22 (11.0) |
VIR-C16 | 4 (2.0) | 30 (15.1) |
VIR-E5 | 20 (10.0) | 26 (13.1) |
VIR-E8 | 5 (2.5) | 30 (15.1) |
AMA-1 | 114 (57.0) | ND |
MSP1 19 | 181 (90.5) | ND |